Courtney leads our U.S. health team with deep expertise in biomedical innovation and health policy. She directs corporate reputation and public affairs campaigns to advance medical research, support vaccine policies, promote consumer health education and elevate the importance of healthcare investment around the world.
Partnering with organizations including Amgen, AstraZeneca, Cigna, Johnson & Johnson, Lilly and Merck, Courtney manages thought leadership and positioning efforts to educate policymakers, healthcare providers and advocacy groups on drug pricing, mental health, cardiovascular disease and patient access. She has provided counsel to the Johns Hopkins Bloomberg School of Public Health, BIO, IFPMA and others on strategies around COVID-19, antibiotic resistance, building vaccine confidence and other public health issues.
Courtney led efforts to elevate the Robert Wood Johnson Foundation and Wellcome Trust with media and health and policy experts. She also oversaw consumer education initiatives with the Consumer Healthcare Products Association including the Stop Medicine Abuse campaign to reduce teen OTC cough medicine abuse and Up and Away and Out of Sight with the CDC to prevent accidental overdoses in young children.
Prior to joining Edelman, Courtney served as vice president, Government Affairs and Communications, for Washington Health Advocates, where she focused on coalition building and federal appropriations strategies for NIH, CDC and FDA. Courtney also managed advocacy programs for the Association of Clinical Research Organizations, collaborating with stakeholders in the U.S., EU and Asia on clinical research policies and education.
Courtney is a member of Chief and has served on the Board of the Center for Study and Information on Clinical Research Participation (CISCRP). She is active in efforts to raise awareness about bone marrow stem cell donation and provide support to blood cancer patients and caregivers. She holds a B.A. in Political Science from Goucher College in Baltimore, MD.